Puma Biotechnology (PBYI) EPS (Basic) (2011 - 2026)
Puma Biotechnology's (PBYI) quarterly EPS (Basic) came in at -$0.07 in Q1 2026, down 223.09% YoY from $0.06 in Q1 2025, and down 121.89% on a QoQ basis from $0.34 in Q4 2025.
Puma Biotechnology (PBYI) EPS (Basic) (2011 - 2026) Analysis & Trends
Puma Biotechnology (PBYI) has 16 years of EPS (Basic) data on file, last reported at -$0.07 in Q1 2026.
- Quarterly EPS (Basic) fell 223.09% year-over-year to -$0.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.55 (up 256.25% YoY) and the FY2025 annual result came in at $0.69, up 19296.54% from the prior year.
- EPS (Basic) eased to -$0.07 in Q1 2026, from $0.34 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.41 in Q3 2024 to a low of -$0.23 in Q4 2024.
- A 5-year average of $0.06 and a median of $0.05 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 1643.85% — and 2024, when it sank 432.61%.
- Tracing PBYI's EPS (Basic) over 5 years: stood at -$0.12 in 2022, then surged by 329.01% to $0.26 in 2023, then plunged by 186.78% to -$0.23 in 2024, then soared by 247.13% to $0.34 in 2025, then sank by 121.89% to -$0.07 in 2026.
- The last three EPS (Basic) figures came in at -$0.07 (Q1 2026), $0.34 (Q4 2025), and $0.18 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Puma Biotechnology | 451.24 Mn | 357.33 Mn | 44.03 Mn | 0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.16 |
| Mar 31, 2026 | -0.07 |
| Dec 31, 2025 | 0.34 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.06 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | 0.41 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | 0.26 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | -0.12 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | -0.08 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | -1.09 |